Literature DB >> 10899839

Differential tumor necrosis factor alpha expression and release from peritoneal mouse macrophages in vitro in response to proliferating gram-positive versus gram-negative bacteria.

W Cui1, D C Morrison, R Silverstein.   

Abstract

Viable Escherichia coli and Staphylococcus aureus bacteria elicited markedly different in vitro tumor necrosis factor alpha (TNF-alpha) responses when placed in coculture with peritoneal murine macrophages. These include quantitative differences in TNF-alpha mRNA expression and corresponding protein product secretion as well as kinetic differences in the profiles of the TNF-alpha responses. Further, lipopolysaccharide (from E. coli) is a major contributing factor to these differences, as revealed by comparative experiments with endotoxin-responsive (C3Heb/FeJ) and endotoxin-hyporesponsive (C3H/HeJ) macrophages. Nevertheless, the eventual overall magnitude of the TNF-alpha secretion of macrophages in response to S. aureus was at least equivalent to that observed with E. coli, while appearing at time periods hours later than the E. coli-elicited TNF-alpha response. Both the magnitude and kinetic profile of the TNF-alpha responses were found to be relatively independent of the rate of bacterial proliferation, at least to the extent that similar results were observed with both viable and paraformaldehyde-killed microbes. Nevertheless, S. aureus treated in culture with the carbapenem antibiotic imipenem manifests markedly altered profiles of TNF-alpha response, with the appearance of an early TNF-alpha peak not seen with viable organisms, a finding strikingly similar to that recently reported by our laboratory from in vivo studies (R. Silverstein, J. G. Wood, Q. Xue, M. Norimatsu, D. L. Horn, and D. C. Morrison, Infect. Immun. 68:2301-2308, 2000). In contrast, imipenem treatment of E. coli-cocultured macrophages does not significantly alter the observed TNF-alpha response either in vitro or in vivo. In conclusion, our data support the concept that the host inflammatory response of cultured mouse macrophages in response to viable gram-positive versus gram-negative microbes exhibits distinctive characteristics and that these distinctions are, under some conditions, altered on subsequent bacterial killing, depending on the mode of killing. Of potential importance, these distinctive in vitro TNF-alpha profiles faithfully reflect circulating levels of TNF-alpha in infected mice. These results suggest that coculture of peritoneal macrophages with viable versus antibiotic-killed bacteria and subsequent assessment of cytokine response (TNF-alpha) may be of value in clarifying, and ultimately controlling, related host inflammatory responses in septic patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899839      PMCID: PMC98339          DOI: 10.1128/IAI.68.8.4422-4429.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

Review 1.  Antibiotics, cytokines, and endotoxin: a complex and evolving relationship in gram-negative sepsis.

Authors:  D L Horn; S M Opal; E Lomastro
Journal:  Scand J Infect Dis Suppl       Date:  1996

2.  Bacterial DNA causes septic shock.

Authors:  T Sparwasser; T Miethke; G Lipford; K Borschert; H Häcker; K Heeg; H Wagner
Journal:  Nature       Date:  1997-03-27       Impact factor: 49.962

3.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

4.  Differential host inflammatory responses to viable versus antibiotic-killed bacteria in experimental microbial sepsis.

Authors:  R Silverstein; J G Wood; Q Xue; M Norimatsu; D L Horn; D C Morrison
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

5.  Roles of the bacterial cell wall and capsule in induction of tumor necrosis factor alpha by type III group B streptococci.

Authors:  J G Vallejo; C J Baker; M S Edwards
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

6.  Bacteremia versus endotoxemia in experimental mouse leukopenia--role of antibiotic chemotherapy.

Authors:  S E Bucklin; D C Morrison
Journal:  J Infect Dis       Date:  1996-12       Impact factor: 5.226

7.  The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure.

Authors:  S J De Kimpe; M Kengatharan; C Thiemermann; J R Vane
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

8.  Comparative study of cytokine release by human peripheral blood mononuclear cells stimulated with Streptococcus pyogenes superantigenic erythrogenic toxins, heat-killed streptococci, and lipopolysaccharide.

Authors:  H Müller-Alouf; J E Alouf; D Gerlach; J H Ozegowski; C Fitting; J M Cavaillon
Journal:  Infect Immun       Date:  1994-11       Impact factor: 3.441

9.  Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo.

Authors:  B A Beutler; I W Milsark; A Cerami
Journal:  J Immunol       Date:  1985-12       Impact factor: 5.422

10.  Serum-induced potentiation of tumor necrosis factor alpha production by human monocytes in response to staphylococcal peptidoglycan: involvement of different serum factors.

Authors:  E Mattsson; J Rollof; J Verhoef; H Van Dijk; A Fleer
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

View more
  8 in total

1.  Mast cells aggravate sepsis by inhibiting peritoneal macrophage phagocytosis.

Authors:  Albert Dahdah; Gregory Gautier; Tarik Attout; Frédéric Fiore; Emeline Lebourdais; Rasha Msallam; Marc Daëron; Renato C Monteiro; Marc Benhamou; Nicolas Charles; Jean Davoust; Ulrich Blank; Bernard Malissen; Pierre Launay
Journal:  J Clin Invest       Date:  2014-09-02       Impact factor: 14.808

2.  17(R)-Resolvin D1 differentially regulates TLR4-mediated responses of primary human macrophages to purified LPS and live E. coli.

Authors:  Christine D Palmer; Christy J Mancuso; Jerrold P Weiss; Charles N Serhan; Eva C Guinan; Ofer Levy
Journal:  J Leukoc Biol       Date:  2011-06-07       Impact factor: 4.962

Review 3.  Receptors, mediators, and mechanisms involved in bacterial sepsis and septic shock.

Authors:  Edwin S Van Amersfoort; Theo J C Van Berkel; Johan Kuiper
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

4.  Lipoprotein lipase and hydrofluoric acid deactivate both bacterial lipoproteins and lipoteichoic acids, but platelet-activating factor-acetylhydrolase degrades only lipoteichoic acids.

Authors:  Ho Seong Seo; Moon H Nahm
Journal:  Clin Vaccine Immunol       Date:  2009-06-24

5.  Protective effect of Toll-like receptor 4 in pulmonary vaccinia infection.

Authors:  Martha A Hutchens; Kathryn E Luker; Joanne Sonstein; Gabriel Núñez; Jeffrey L Curtis; Gary D Luker
Journal:  PLoS Pathog       Date:  2008-09-19       Impact factor: 6.823

6.  CcpA Affects Infectivity of Staphylococcus aureus in a Hyperglycemic Environment.

Authors:  Markus Bischoff; Bodo Wonnenberg; Nadine Nippe; Naja J Nyffenegger-Jann; Meike Voss; Christoph Beisswenger; Cord Sunderkötter; Virginie Molle; Quoc Thai Dinh; Frank Lammert; Robert Bals; Mathias Herrmann; Greg A Somerville; Thomas Tschernig; Rosmarie Gaupp
Journal:  Front Cell Infect Microbiol       Date:  2017-05-09       Impact factor: 5.293

7.  Endogenous TNFα orchestrates the trafficking of neutrophils into and within lymphatic vessels during acute inflammation.

Authors:  Samantha Arokiasamy; Christian Zakian; Jessica Dilliway; Wen Wang; Sussan Nourshargh; Mathieu-Benoit Voisin
Journal:  Sci Rep       Date:  2017-03-13       Impact factor: 4.379

8.  Staphylococcus aureus Lung Infection Results in Down-Regulation of Surfactant Protein-A Mainly Caused by Pro-Inflammatory Macrophages.

Authors:  Elisabeth Schicke; Zoltán Cseresnyés; Knut Rennert; Vanessa Vau; Karoline Frieda Haupt; Franziska Hornung; Sandor Nietzsche; Fatina Swiczak; Michaela Schmidtke; Brigitte Glück; Mirijam Koch; Michael Schacke; Regine Heller; Alexander S Mosig; Marc Thilo Figge; Christina Ehrhardt; Bettina Löffler; Stefanie Deinhardt-Emmer
Journal:  Microorganisms       Date:  2020-04-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.